
Your Feed
Filter by
See content from
Playlist: ASH 2025
High-Risk DLBCL: GOLCA Boosts Remission Rates | Marc Hoffmann, MD
Video details & playlist
Playlist: ASH 2025
Chemo-Free Option for Frail Lymphoma Patients | Umberto Vitolo, MD
Video details & playlist
Playlist: ASH 2025
What Happens When You Add Mosunetuzumab + Polatuzumab to CAR‑T (axi‑cel)? | Jay Spiegel, MD
Video details & playlist














